Opinion|Videos|June 12, 2024
Optimizing PAH Care Delivery for Better Outcomes
Author(s)Marius Hoeper, MD
Following a review of strategies and care delivery models that could help optimize the management of PAH, Marius Hoeper, MD, discusses his recent publication on the long-term impact of sotatercept on morbidity and mortality.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- From a clinical perspective, what strategies or care delivery models could help optimize the management of pulmonary arterial hypertension (PAH) and potentially reduce the overall burden on the health care system while improving patient outcomes?
- Discuss your recent publication on using a population health model to predict the long-term impact of the new PAH therapy sotatercept on morbidity and mortality. How can such modeling tools be leveraged by clinicians to better anticipate and plan for the clinical and economic effects of emerging PAH treatments?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
2
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
3
Value-Based Care Interventions and Management of CKD Progression
4
Defining the Role of Rilzabrutinib in ITP Management
5
